Literature DB >> 8092093

Caffeine and bone loss in healthy postmenopausal women.

S S Harris1, B Dawson-Hughes.   

Abstract

The effects of caffeine consumption on rates of change in bone mineral density (BMD) were examined in 205 healthy, nonsmoking, postmenopausal women. BMD of the spine and total body were measured by dual-energy x-ray absorptiometry, and dietary intakes by food-frequency questionnaire. Among women with calcium intakes above the median (744 mg/d), 1-y rates of bone change--adjusted for years since menopause, body mass index, physical activity, and baseline BMD--did not differ by caffeine intake. However, among women consuming less calcium, those with the highest caffeine intakes (> 450 mg/d) had significantly more bone loss (ANCOVA, P < 0.05) than did women consuming less caffeine (0-171 and 182-419 mg/d). Percent change in BMD by lowest to highest tertile of caffeine consumption was 0.26 +/- 2.74, 0.70 +/- 2.70, and -1.36 +/- 2.70 at the spine and -0.19 +/- 1.24, 0.23 +/- 1.23, and -0.68 +/- 1.25 at the total body. Daily consumption of caffeine in amounts equal to or greater than that obtained from about two to three servings of brewed coffee may accelerate bone loss from the spine and total body in women with calcium intakes below the recommended dietary allowance of 800 mg.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092093     DOI: 10.1093/ajcn/60.4.573

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  27 in total

1.  Familial resemblance of bone mineral density between females 18 years and older and their mothers.

Authors:  D Picard; A Imbach; M Couturier; R Lepage; M Picard
Journal:  Can J Public Health       Date:  2001 Sep-Oct

2.  Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women.

Authors:  H Hallström; A Wolk; A Glynn; K Michaëlsson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

Review 3.  Caffeine use in children: what we know, what we have left to learn, and why we should worry.

Authors:  Jennifer L Temple
Journal:  Neurosci Biobehav Rev       Date:  2009-01-20       Impact factor: 8.989

4.  Is the Ergogenicity of Caffeine Affected by Increasing Age? The Direct Effect of a Physiological Concentration of Caffeine on the Power Output of Maximally Stimulated EDL and Diaphragm Muscle Isolated from the Mouse.

Authors:  J Tallis; R S James; V M Cox; M J Duncan
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Adenosine A2B receptors play an important role in bone homeostasis.

Authors:  Carmen Corciulo; Tuere Wilder; Bruce N Cronstein
Journal:  Purinergic Signal       Date:  2016-06-11       Impact factor: 3.765

6.  Soda consumption and risk of hip fractures in postmenopausal women in the Nurses' Health Study.

Authors:  Teresa T Fung; Meredith H Arasaratnam; Francine Grodstein; Jeffrey N Katz; Bernard Rosner; Walter C Willett; Diane Feskanich
Journal:  Am J Clin Nutr       Date:  2014-08-06       Impact factor: 7.045

7.  Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study.

Authors:  Helena Hallström; Håkan Melhus; Anders Glynn; Lars Lind; Ann-Christine Syvänen; Karl Michaëlsson
Journal:  Nutr Metab (Lond)       Date:  2010-02-22       Impact factor: 4.169

8.  Factors affecting bone mineral density in men.

Authors:  Ebru Atalar; Gülümser Aydin; Isik Keles; Elem Inal; Gulfer Zog; Ayse Arslan; Sevim Orkun
Journal:  Rheumatol Int       Date:  2008-12-10       Impact factor: 2.631

9.  Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use.

Authors:  C M Wetmore; L Ichikawa; A Z LaCroix; S M Ott; D Scholes
Journal:  Osteoporos Int       Date:  2007-10-09       Impact factor: 4.507

Review 10.  Epidemiology of osteoporosis.

Authors:  Elizabeth J Samelson; Marian T Hannan
Journal:  Curr Rheumatol Rep       Date:  2006-02       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.